Patent ID: 9555027
Date: 2017-01-31
CPC Classifications: A61K,A61P,C07D

Claim:
1. An oral preparation, comprising: N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1′R,2′S,3′R,4′S)-2,3-bicyclo[2,2,1]heptanedicarboxyimide hydrochloride (lurasidone) of formula (1): a pregelatinized starch; a water-soluble excipient; and a water-soluble polymer binder, wherein lurasidone is included in the preparation in an amount of from 20 to 45% (wt/wt), and the pregelatinized starch is included in the preparation in an amount of from 10 to 50% (wt/wt).